EurekAlert! News by Subject: Medicine & Health - Home

Medicine & Health

Updates every hour. Last Updated: 6-Jun-2026 19:15 ET (6-Jun-2026 23:15 GMT/UTC)

Major NIH grant renewal fuels next phase of chronic pain research at UT Health San Antonio School of Dentistry

The University of Texas at San Antonio Health Science Center
Grant and Award Announcement

The School of Dentistry at UT Health San Antonio, the academic health center of The University of Texas at San Antonio, received a major National Institutes of Health grant renewal to examine the biological mechanisms of temporomandibular joint (TMJ) disorder, aimed at developing the first targeted, non-opioid treatment for chronic pain.

The Journal of Nuclear Medicine ahead-of-print tip sheet: February 27, 2026

Society of Nuclear Medicine and Molecular Imaging
Peer-Reviewed Publication

New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society of Nuclear Medicine and Molecular Imaging, an international scientific and medical organization dedicated to advancing nuclear medicine, molecular imaging, and theranostics—precision medicine that allows diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes.

Journal: Journal of Nuclear Medicine

New paper examines dementia inequities in Indigenous communities and the power of cultural resilience

University of Minnesota Medical School
Peer-Reviewed Publication

An international collaboration, co-led by a University of Minnesota Medical School researcher, has published a new paper in Alzheimer’s & Dementia that opens in the same window synthesizing global evidence on the origins of dementia inequities in Indigenous communities and how community strengths can inform brain health research worldwide.

Funder: National Health and Medical Research Council, National Institute for Health Research, Dementia Australia Research Foundation, Alzheimer's Association, Fonds de recherche du Québec – Santé

Blood test predicts which bladder cancer patients may safely skip surgery

Temple University Health System
Peer-Reviewed Publication

Circulating tumor DNA, or ctDNA, can predict metastatic risk in patients who receive bladder-sparing treatment for muscle-invasive bladder cancer, but it is not a good predictor of local recurrence within the bladder, according to new data presented today by Fox Chase Cancer Center researchers.

Journal: Journal of Clinical Oncology
Meeting: American Society of Clinical Oncology's Genitourinary Cancers Sympoium.

Can the canny tick help prevent disease like MS and cancer?

Monash University
Peer-Reviewed Publication

A team from the Monash University Biomedicine Discovery Institute in Australia has identified a tick-derived evasin that can bind to two major classes of chemokines, a discovery that is important for the development of therapeutics targeting inflammatory and autoimmune diseases. Until now, scientists had identified only evasins that selectively block chemokines within a single class.

Journal: Structure

Newcomer children show lower rates of emergency department use for non‑urgent conditions, study finds

Institute for Clinical Evaluative Sciences
Peer-Reviewed Publication

Refugee and immigrant children are less likely to visit the emergency department (ED) for minor illnesses (e.g., respiratory infections) compared to children born in Ontario, according to a new study from ICES and The Hospital for Sick Children (SickKids).

Journal: JAMA Network Open

Cognitive and neuropsychiatric function in former American football players

JAMA Network
Peer-Reviewed Publication

About The Study: In this cross-sectional study of former American football players, prior American football participation was associated with worse later-life cognitive and neuropsychiatric function. These findings support a dose-response association with years and level of play, providing context to help clinicians and researchers assess the risk of symptoms among former players.

Journal: JAMA Network Open

Acoziborole Winthrop, developed by DNDi and Sanofi, receives European Medicines Agency positive opinion as three-tablet, single-dose treatment for most common form of sleeping sickness

Drugs for Neglected Diseases Initiative
Business Announcement

Recommendation based on Phase II/III study demonstrating up to 96 per cent success rates at 18 months across both early and advanced stages of T.b. gambiense, the most common form of sleeping sickness

The therapy, given as a single dose of three tablets, could offer a simpler alternative to longer, more complex regimens and help support the World Health Organization’s (WHO) goal of eliminating the disease by 2030

Sanofi will donate the medicine to WHO through its philanthropic arm Foundation S

Study identifies opposing roles for IL6 and IL6R in long-term mortality

Impact Journals LLC
Peer-Reviewed Publication

BUFFALO, NY — February 27, 2026 — A new research paper was published in Volume 18 of Aging-US on February 6, 2026, titled “Causal effects of inflammation on long-term mortality: a Mendelian randomization study.”

Journal: Aging-US